Stylus Medicine Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Stylus Medicine, Inc. (“Stylus”), a biotechnology company dedicated to developing transformative in vivo... Read more.
Perion Reports First Quarter 2025 Results, Raising Full Year 2025 Outlook
Key Growth Engines Continue to Deliver Strong Organic Performance with 80% Growth in Digital Out of Home, 31% in CTV and 33% in Retail Media NEW YORK & TEL AVIV,... Read more.
Adastra Joins Austin’s Thriving Tech Ecosystem with New Office in Texas
LOS ANGELES–(BUSINESS WIRE)–Adastra Group (also known as Adastra Corporation), a global leader in data analytics and artificial intelligence, is pleased... Read more.
SciAps Advances Precision Spectral Analysis with FieldSpec, TerraSpec, and LabSpec
ANDOVER, Mass.–(BUSINESS WIRE)–SciAps Inc., a leader in handheld and portable analytical instruments, announces the continued evolution of the FieldSpec,... Read more.
Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full Potential of CAR-T Therapy
─ $85 million in financing includes recent $45 million Series A extension with participation from founding investors RA Capital Management and Khosla Ventures... Read more.
Pritzker Private Capital Adds Andrew Farwell and Patrick Hodan Vice Presidents
Additions Support PPC’s Investment Initiatives in the Manufactured Products and Services Sectors CHICAGO–(BUSINESS WIRE)–Pritzker Private Capital... Read more.
Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025
SAIL-0804 shows rapid and deep B cell depletion along with repopulation by mostly immature phenotypes in preclinical models, supporting its advancement into IND-enabling... Read more.
Shareholder Alert: The Ademi Firm investigates whether Landsea Homes Corporation is obtaining a Fair Price for its Public Shareholders
MILWAUKEE–(BUSINESS WIRE)–The Ademi Firm is investigating Landsea Homes (Nasdaq: LSEA) for possible breaches of fiduciary duty and other violations of... Read more.
Sea Limited Reports First Quarter 2025 Results
SINGAPORE–(BUSINESS WIRE)–Sea Limited (NYSE: SE) (“Sea” or the “Company”) today announced its financial results for the first... Read more.
UnitedHealth Group Announces Leadership Transition
Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to... Read more.